Linden to invest in healthcare RCM firm Aspirion

When the deal closes, Aspirion's previous backer Aquiline Capital Partners will remain an investor.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this